We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Andre Rogatko, PhD

Director, Biostatistics and Bioinformatics Research Center

Andre Rogatko, PhD

Director, Biostatistics and Bioinformatics Research Center

The research of Andre Rogatko, PhD, focuses on using statistical methods to improve the design and analysis of clinical trials, genetic epidemiology, and risk prediction.

Click here for a list of peer-reviewed publications.

  • Babb J, Rogatko A, Zacks S. Cancer phase I clinical trials: efficient dose escalation with overdose control. Stat Med. 1998;17(10):1103-1120.
  • Rogatko A, Babb J, Jordan H, Zacks S. Constructing meiotic maps with known error probability. Genet Epidemiol. 1999;16(3):274-289.
  • Rogatko A, Babb JS, Tighiouart M, Khuri FR, Hudes G. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I. Clin Cancer Res. 2005;11(15):5342-5346.
  • Rogatko A, Babb JS, Wang H, Slifker MJ, Hudes GR. Patient characteristics compete with dose as predictors of acute treatment toxicity in early phase clinical trials. Clin Cancer Res. 2004;10(14):4645-4651.
  • Rogatko A, Schoeneck D, Jonas W, Tighiouart M, Khuri FR, Porter A. Translation of innovative designs into phase I trials. J Clin Oncol. 2007;25(31):4982-4986.
  • Rogatko A, Slifker MJ, Babb JS. Hardy-Weinberg equilibrium diagnostics. Theor Popul Biol. 2002;62(3):251-257.

Show moreShow less

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Andre Rogatko, PhD